Torrent Pharmaceuticals Limited has once again expanded its recall of Losartan potassium tablets and Losartan potassium/hydrochlorothiazide tablets, the Food and Drug Administration announced Thursday.

The company has added an additional 36 lots of Losartan potassium tablets and 68 lots of Losartan potassium/hydrochlorothiazide tablets.

>> Read more trending news

The recall is due once again to an impurity called N-Methylnitrosobutric acid or NMBA.

The recalled lots have more NMBA than what is acceptable for daily intake set by the FDA.

Consumers with medical questions connected to the recall are being instructed to call Torrent Pharmaceuticals at 1-800-912-9561 or email Medinfo.Torrent@apcerls.com.

For more information, including the complete list of batch numbers included with the recall's expansion, click here.

About the Author

Featured

Corbin Spencer, right, field director of New Georgia Project and volunteer Rodney King, left, help Rueke Uyunwa register to vote. The influential group is shutting down after more than a decade. (Hyosub Shin/AJC 2017)

Credit: Hyosub Shin